AU2009319667B2 - Peptide adjuvants - Google Patents

Peptide adjuvants Download PDF

Info

Publication number
AU2009319667B2
AU2009319667B2 AU2009319667A AU2009319667A AU2009319667B2 AU 2009319667 B2 AU2009319667 B2 AU 2009319667B2 AU 2009319667 A AU2009319667 A AU 2009319667A AU 2009319667 A AU2009319667 A AU 2009319667A AU 2009319667 B2 AU2009319667 B2 AU 2009319667B2
Authority
AU
Australia
Prior art keywords
seq
peptide
antigen
adjuvant
response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2009319667A
Other languages
English (en)
Other versions
AU2009319667A1 (en
Inventor
Shawn Babiuk
Darwyn Kobasa
Gary Kobinger
Ami Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canada Minister of National Health and Welfare
Original Assignee
Canada Minister of National Health and Welfare
Canada Minister of Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canada Minister of National Health and Welfare, Canada Minister of Health filed Critical Canada Minister of National Health and Welfare
Publication of AU2009319667A1 publication Critical patent/AU2009319667A1/en
Application granted granted Critical
Publication of AU2009319667B2 publication Critical patent/AU2009319667B2/en
Priority to AU2016201589A priority Critical patent/AU2016201589B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2009319667A 2008-11-28 2009-11-30 Peptide adjuvants Ceased AU2009319667B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2016201589A AU2016201589B2 (en) 2008-11-28 2016-03-11 Peptide adjuvants

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11853308P 2008-11-28 2008-11-28
US61/118,533 2008-11-28
PCT/CA2009/001707 WO2010060208A1 (en) 2008-11-28 2009-11-30 Peptide adjuvants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016201589A Division AU2016201589B2 (en) 2008-11-28 2016-03-11 Peptide adjuvants

Publications (2)

Publication Number Publication Date
AU2009319667A1 AU2009319667A1 (en) 2011-06-23
AU2009319667B2 true AU2009319667B2 (en) 2016-03-03

Family

ID=42225170

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2009319667A Ceased AU2009319667B2 (en) 2008-11-28 2009-11-30 Peptide adjuvants
AU2016201589A Ceased AU2016201589B2 (en) 2008-11-28 2016-03-11 Peptide adjuvants

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2016201589A Ceased AU2016201589B2 (en) 2008-11-28 2016-03-11 Peptide adjuvants

Country Status (8)

Country Link
US (2) US8404243B2 (enExample)
EP (2) EP2370100B1 (enExample)
JP (2) JP5656857B2 (enExample)
AU (2) AU2009319667B2 (enExample)
CA (1) CA2740566C (enExample)
ES (2) ES2615120T3 (enExample)
NZ (1) NZ593200A (enExample)
WO (1) WO2010060208A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9758548B2 (en) * 2011-05-11 2017-09-12 Technion Research & Development Foundation Limited Anti-microbial peptides and uses of same
WO2013154744A1 (en) 2012-04-13 2013-10-17 Cornell University Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction
CA3100236A1 (en) * 2020-11-20 2022-05-20 Universite Laval Severe acute respiratory syndrome coronavirus dna vaccines

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019494A1 (en) * 1994-12-19 1996-06-27 Biochem Pharma Inc. Peptides having immunomodulatory activity
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090087878A9 (en) * 1999-05-06 2009-04-02 La Rosa Thomas J Nucleic acid molecules associated with plants
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
US7371837B2 (en) * 2004-07-21 2008-05-13 The University Of Hong Kong Human virus causing respiratory tract infection and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
WO1996019494A1 (en) * 1994-12-19 1996-06-27 Biochem Pharma Inc. Peptides having immunomodulatory activity

Also Published As

Publication number Publication date
ES2615120T3 (es) 2017-06-05
CA2740566A1 (en) 2010-06-03
ES2541443T3 (es) 2015-07-20
AU2009319667A1 (en) 2011-06-23
AU2016201589B2 (en) 2016-11-24
US8404243B2 (en) 2013-03-26
EP2987502A1 (en) 2016-02-24
JP2015091811A (ja) 2015-05-14
NZ593200A (en) 2012-10-26
EP2370100A1 (en) 2011-10-05
WO2010060208A1 (en) 2010-06-03
CA2740566C (en) 2017-11-28
US9211325B2 (en) 2015-12-15
EP2370100A4 (en) 2013-05-22
JP5901084B2 (ja) 2016-04-06
AU2016201589A1 (en) 2016-03-31
EP2987502B1 (en) 2016-11-09
JP5656857B2 (ja) 2015-01-21
EP2370100B1 (en) 2015-04-08
JP2012509906A (ja) 2012-04-26
US20110305720A1 (en) 2011-12-15
US20130323285A1 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
KR102356869B1 (ko) 면역원성 화합물
KR102625645B1 (ko) B형 간염 바이러스에 대한 백신
TW201420114A (zh) 口蹄疫合成胜肽緊急疫苗
US20230143215A1 (en) Immunization against sars-cov-related diseases
TWI754817B (zh) 以人工混雜ｔ輔助細胞抗原決定位以有限度的ｔ細胞發炎反應促進目標抗體的生產
JP2010506926A (ja) Ｉｉ−Ｋｅｙ増強ワクチンの効力
AU2016201589B2 (en) Peptide adjuvants
Moisa et al. Synthetic peptide vaccines
AU2011360572B2 (en) Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
Moisa et al. Synthetic peptide vaccines
CN113476600B (zh) Avc-29作为疫苗佐剂的用途以及含有该佐剂的疫苗组合物
Arnon et al. Peptide-based synthetic recombinant vaccines with anti-viral efficacy
CA3173307A1 (en) Vaccines against viral pathogens
US11344614B2 (en) Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopes
HK40067424A (en) Pharmaceutical compositions comprising combination of immunogenic peptides
HK40045220A (en) Artificial promiscuous t helper cell epitopes that facilitate targeted antibody production with limited t cell inflammatory response
Ben-Yedidia A peptide-based vaccine against influenza

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired